General Information of the Compound
Compound ID
CP0061816
Compound Name
2-(Diphenyl-methanesulfinyl)-acetamide
    Show/Hide
Synonyms
Modafinil
Modiodal
Provigil
    Show/Hide
Structure
Formula
C15H15NO2S
Molecular Weight
273.357
Canonical SMILES
NC(=O)CS(=O)C(c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)
    Show/Hide
InChIKey
YFGHCGITMMYXAQ-UHFFFAOYSA-N
CAS
112111-49-6
68693-11-8
112111-43-0
Physicochemical Property
logP
2.01
Rotatable Bonds
5
Heavy Atom Count
19
Polar Areas
60.16
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 4236
SID: 14897309
ChEMBL ID
CHEMBL1373
DrugBank ID
DB00745
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 13335.9 nM
   TI
   LI
   LO
   TS
Protein ID: PT00884, Sodium-dependent dopamine transporter
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 11500 nM
   TI
   LI
   LO
   TS
CL000053 COS-7 Chlorocebus aethiops (Green monkey)  3
1
Ki = 927 nM
   TI
   LI
   LO
   TS
2
Ki = 3090 nM
   TI
   LI
   LO
   TS
3
Ki = 13000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 2000 nM
Clinical Information about the Compound
Drug 1 ( Modafinil )
Drug Name Modafinil
Company Cephalon Inc
Indication
Narcolepsy
Approved
Bipolar disorder
Phase 4
Brain injury
Investigative
Target(s)
Dopamine transporter (DAT)
Modulator